Global Seed Treatment Fungicides Market Trends and Insights
Rising Seed-Borne and Soil-Borne Disease Pressure
Cool and wet planting conditions have increased seed and seedling exposure to Fusarium, Rhizoctonia, and Pythium in North America and Europe. These pathogens can damage plants before their defenses are fully established, making preventive treatment important. A 2025 review published in Agronomy found that fungal diseases cause 15% to 20% of global crop losses, rising to 50% during severe disease events. Disease forecasting services are helping growers adopt preseason treatment protocols rather than waiting for visible symptoms. This shift supports steadier demand in the seed treatment fungicides market, including in seasons with lower disease incidence, and increases the value of treatments that protect early crop establishment across varied planting conditions.Higher Adoption of Commercially Treated Seed
Commercial seed companies and professional treaters now handle a large share of cereal and row-crop seed treatment in North America and South America. Calibrated equipment improves active ingredient placement, seed coverage, and product compatibility. This approach reduces the variability associated with on-farm treatment and supports more predictable product performance. It also shifts purchasing decisions toward larger commercial treaters, reducing farm-level price competition. Meanwhile, hybrid seed programs across other emerging markets are supporting a gradual transition from farm-saved seed to treated varieties. This pattern creates a broader addressable base for suppliers serving the seed treatment fungicides market.Fungicide Resistance and Shrinking Mode-of-Action Options
Resistance to succinate dehydrogenase inhibitors is advancing in Zymoseptoria tritici populations across Northern and Eastern Europe. A 2026 study published in the European Journal of Plant Pathology documented SDHI target site alterations associated with reduced fungicide sensitivity and high cross resistance between SDHI fungicides. Resistance management can limit how often particular active ingredients are used during a crop cycle, reducing the flexibility of products that rely on a single mode of action. Product developers therefore need to plan new active ingredients as part of a broader mixture and stewardship strategy. These restrictions can slow product adoption in the Seed treatment fungicides market where established chemistries face tighter use guidance.Other drivers and restraints analyzed in the detailed report include:
- Biological Fungicide Pipeline Expansion
- Multi-Mode Fungicide Premixes for Resistance Management
- National Registration and Data-Compliance Burden
Segment Analysis
Chemical fungicides accounted for 72% of the seed treatment fungicides market size in 2025, supported by established registrations, recognized efficacy, and practical use at commercial treatment facilities. The Seed treatment fungicides market size for chemical products remains linked to concentrated synthetic actives that can be applied efficiently to high seed volumes. Triazole-SDHI combinations, strobilurins, and phenylpyrroles remained widely used in cereal, oilseed, and pulse treatment programs during 2025. Chemical products offer broad coverage against seed-borne and soil-borne pathogens across the main producing regions, and their established performance supports continued use where growers need predictable protection at planting.Biological fungicides represented the remaining value and are forecast to grow at a 10% CAGR through 2031. This segment benefits from demand for residue-compliant treatments and products suitable for organic or lower-residue crop programs. BASF SE's Integral Pro platform had protected several million hectares of oilseed rape annually in Europe before its sunflower registration expanded in France during November 2025. Formulation improvements are helping biological products withstand commercial treatment equipment and storage conditions, which can extend their use beyond high-value niche crops into larger cereal and oilseed programs.
Triazoles held 28% of 2025 active ingredient revenue because they provide broad control of Fusarium, smut, bunt, and rust diseases. This class has a broad global registration base and remains important in cereal and oilseed protection. Strobilurins, carboxamides, and phenylamides also represented significant shares of the market in 2025. Phenylpyrroles, led by fludioxonil provided an important resistance-management role. These classes are increasingly used in mixtures rather than in standalone products.
Carboxamides are forecast to grow at a 10.2% CAGR through 2031, the fastest rate among active ingredient classes. Their growth reflects their activity against Rhizoctonia solani, which triazoles do not fully manage. Bayer AG introduced EverGol Rise in Canada during December 2025 with multiple active ingredients for pulse disease control. Phenylamides remain necessary for oomycete management in legumes and potatoes. New SDHI subclasses and biological actives are also anticipated to add volume as more pipeline products reach commercial scale.
Complete Report Scope:
- By Fungicide Type
- Chemical Fungicides
- Biological Fungicides
- By Active Ingredient Class
- Triazoles
- Strobilurins
- Carboxamides
- Phenylamides
- Phenylpyrroles
- Other Active Ingredient Classes
- By Formulation
- Liquid
- Powder and Dry
- Flowable Concentrate
- Suspension Concentrate
- By Crop Type
- Cereals and Grains
- Oilseeds and Pulses
- Fruits and Vegetables
- Turf and Ornamentals
- Fiber Crops
- Silage and Forage Crops
- By Geography
- North America
- United States
- Canada
- Mexico
- Rest of North America
- South America
- Brazil
- Argentina
- Chile
- Rest of South America
- Europe
- Russia
- France
- Germany
- Italy
- Spain
- United Kingdom
- Netherlands
- Rest of Europe
- Asia-Pacific
- China
- India
- Japan
- Australia
- Indonesia
- Thailand
- Vietnam
- Philippines
- Rest of Asia-Pacific
- Middle East
- Turkey
- Saudi Arabia
- United Arab Emirates
- Rest of Middle East
- Africa
- South Africa
- Egypt
- Nigeria
- Rest of Africa
- North America
Geography Analysis
North America accounted for 31% of 2025 revenue, reflecting a relatively mature market with established commercial seed-treatment practices. The regional market is characterized by demand for higher-value treatment solutions and continued product development. In the United States, regulatory approvals continue to expand the range of seed-applied fungicide tools available to commercial formulators. The U.S. Environmental Protection Agency (US EPA) registered florylpicoxamid, a broad-spectrum fungicide, in May 2025, expanding the active-ingredient pipeline and providing growers and formulators with an additional mode of action for disease control and resistance management.South America is forecast to grow at an 10.1% CAGR through 2031. Brazil and Argentina drive demand through large soybean and corn cultivation areas and widespread use of commercially treated seed. Chile and other regional markets contribute demand for specialty and vegetable seed treatments. Brazil is also relevant for biological production investment and commercialization. Local residue requirements are increasing interest in low-residue biological and encapsulated chemical products, supporting continued expansion in the seed treatment fungicides market across major row crops.
Europe maintains strong demand for seed treatment fungicides, although active ingredient phase-outs and European Union review processes are limiting chemical options and creating opportunities for biological alternatives. Asia-Pacific is supported by expanding commercial agriculture and increasing adoption of treated seeds, with China and India serving as major demand centers due to their large cereal, oilseed, and vegetable production bases. The Middle East and Africa are driven by increasing demand for crop protection in Turkey, South Africa, Nigeria, and Egypt, particularly across cereal and horticultural crops. Limited purchasing power and constrained formal seed-system reach continue to limit African market penetration despite significant disease pressure.
List of Companies Covered in this Report:
- Bayer AG
- Syngenta Group AG
- BASF SE
- Corteva Agriscience, Inc.
- FMC Corporation
- UPL Limited
- Sumitomo Chemical Company, Limited
- Nufarm Limited
- Certis Belchim B.V.
- Koppert Biological Systems B.V.
- PI Industries Limited
- Rallis India Limited
- Albaugh, LLC
- Gowan Company, LLC
- Germains Seed Technology Ltd.
Additional Benefits:
- The market estimate (ME) sheet in Excel format
- 3 months of analyst support
Table of Contents
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Bayer AG
- Syngenta Group AG
- BASF SE
- Corteva Agriscience, Inc.
- FMC Corporation
- UPL Limited
- Sumitomo Chemical Company, Limited
- Nufarm Limited
- Certis Belchim B.V.
- Koppert Biological Systems B.V.
- PI Industries Limited
- Rallis India Limited
- Albaugh, LLC
- Gowan Company, LLC
- Germains Seed Technology Ltd.

